Literature DB >> 12769186

Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis.

Guillaume Bassez1, Francois-Jérôme Authier, Emmanuèle Lechapt-Zalcman, Marie Hélène Delfau-Larue, Anne Plonquet, Michelle Coquet, Isabel Illa, Romain K Gherardi.   

Abstract

We describe the unreported pattern of inflammatory myopathy with abundant macrophages (IMAM) as a main differential diagnosis of postimmunization aluminum hydroxide-induced macrophagic myofasciitis (MMF). IMAM was mainly detected among patients with a dermatomyositis (DM)-like disease. Among 113 muscle biopsies from DM patients collected from 1974 to 2000, intensity of macrophage infiltration was highly variable: 41.5% (-/+); 34.5% (+); 17% (++): and 7% (+++). The 27 patients from groups (++) and (+++) had a similar pattern of macrophagic infiltration and were considered to have IMAM. They were compared to 40 MMF patients. In IMAM, macrophage infiltrates were diffuse and correlated positively with both T cell infiltrates and acute muscle fiber damage, and showed pictures of hemophagocytosis (21/27). Connective tissue structures were infiltrated by noncohesive, ribbon-forming collections of large basophilic macrophages containing no crystalline inclusions. In MMF, macrophage infiltrates were focal and formed compact well-delineated aggregates of granular PAS+ cells, loaded with crystalline aluminum hydroxide particles, in the absence of either hemophagocytosis or conspicuous muscle damage. Review of the literature indicates similarities between IMAM and "cytophagic histiocytic panniculitis" (CHP), a condition characterized by T cell-triggered macrophage hyperactivation. Both IMAM and CHP, but not MMF, may be associated with a life-threatening hemophagocytic syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 12769186     DOI: 10.1093/jnen/62.5.464

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population.

Authors:  Shintaro Hara; Tomoko Henmi; Atsushi Kawakami; Keita Fujikawa; Hiroshi Mukae; Yuji Ishimatsu; Noriho Sakamoto; Tomoyuki Kakugawa; Kenzou Kaji; Manabu Fujimoto; Masataka Kuwana; Toshiaki Tsukada; Katsuya Satoh; Masakatsu Motomura; Mami Tamai; Hideki Nakamura; Hiroaki Ida; Tomayoshi Hayashi; Tomoki Origuchi; Katsumi Eguchi; Shigeru Kohno
Journal:  Rheumatol Int       Date:  2010-12-02       Impact factor: 2.631

2.  Immune myopathy with large histiocyte-related myofiber necrosis.

Authors:  Alan Pestronk; Namita Sinha; Ziad Alhumayyd; Cindy Ly; Robert Schmidt; Robert Bucelli
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

3.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

4.  MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages.

Authors:  K Fujikawa; K Migita; Y Shigemitsu; M Umeda; F Nonaka; M Tamai; H Nakamura; A Mizokami; T Tsukada; T Origuchi; N Yonemitsu; M Yasunami; A Kawakami; K Eguchi
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 5.  Biopersistence and brain translocation of aluminum adjuvants of vaccines.

Authors:  Romain Kroum Gherardi; Housam Eidi; Guillemette Crépeaux; François Jerome Authier; Josette Cadusseau
Journal:  Front Neurol       Date:  2015-02-05       Impact factor: 4.003

6.  Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.

Authors:  Rati Chkheidze; Dennis K Burns; Charles L White; Diana Castro; Julie Fuller; Chunyu Cai
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

7.  Vacuolar myopathy in a dog resembling human sporadic inclusion body myositis.

Authors:  Jason King; Richard A LeCouteur; Monica Aleman; D Colette Williams; Peter F Moore; Ling T Guo; Andrew P Mizisin; G Diane Shelton
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

8.  Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.

Authors:  S A Yasin; P W Schutz; C T Deakin; E Sag; H Varsani; S Simou; L R Marshall; S L Tansley; N J McHugh; J L Holton; L R Wedderburn; T S Jacques
Journal:  Neuropathol Appl Neurobiol       Date:  2019-03-11       Impact factor: 8.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.